Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 medications to support her weight loss goal. After six months on Wegovy ...

Novo Nordisk is making a strategic push into India's weight-loss market to secure its position ahead of competition from ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Despite their benefits, there are a number of things to consider before taking weight loss drugs – including possible ...

The liver is responsible for more than 500 functions in the human body, including filtering harmful substances from the blood ...

They have been called miraculous and the fastest way to lose weight, but how exactly do these weight loss-drugs work – and ...

HHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...